Hysteroscopic Tubal Cannulation & Foam Contrast Hydrotubation for the Treatment of Proximal Tubal Occlusion and Tubal Patency Assessment

Abstract

<h3>Study Objective</h3> To assess the feasibility, benefits and advantages of combining hysteroscopic fallopian tube cannulation with selective foam contrast hydrotubation and pelvic ultrasonography in the treatment of proximal fallopian tube occlusion and simultaneous tubal patency confirmation. <h3>Design</h3> Case Series from September 2020 to March 2021. <h3>Setting</h3> Day case outpatient procedure in a hysteroscopy suite. <h3>Patients or Participants</h3> 10 patients diagnosed with proximal fallopian tube occlusion, desirous of natural fertility and consented for hysteroscopic tubal cannulation and foam contrast hydrotubation and pelvic sonography. <h3>Interventions</h3> Hysteroscopic fallopian tube cannulation, using a vaginoscopic approach under conscious sedation with the patient in the dorsal lithotomy position and under aseptic conditions, selective foam contrast hydrotubation at hysteroscopy simultaneous pelvic ultrasound assessment of tubal patency post procedure. <h3>Measurements and Main Results</h3> 1. Successful Hysteroscopy 2. Successful Tubal Cannulation and foam contrast hydrotubation. 3. Demonstration of tubal patency. 4. Pain Score. 5. Complications. 6 Procedure time 7. Patient convalescence. 8. Pregnancy outcome post procedure. <h3>Conclusion</h3> Outpatient hysteroscopic tubal cannulation with foam contrast hydrotubation in patients with proximal fallopian tube occlusion is a safe, feasible, comfortable method that allows for simultaneous confirmation of tubal patency. The method avoids the need for a simultaneous laparoscopic or radiographic procedure thus saving time and reducing costs.